Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wpforms-lite domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the astra domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6121
Daniel Cartwright

LEADERSHIP TEAM

CHAIRMAN OF THE BOARD

Daniel Cartwright, Chairman of the Board, is co-founder of SarcoMed USA in 2017. He attended Indiana University, Bloomington, IN; undergraduate from 1972-1976; George Washington University, Washington, D.C., graduate school from 1976-1979; South Texas College of Law, Houston, Texas, J.D. 1980-1983. Mr. Cartwright is a member of the State Bar of Texas from 1983-present, having served on various committees including, Chairman of Board of Disciplinary Appeals; member of District Disability Committee; and Lawyer’s Assistance Committee. He is also a member of the Houston Bar Association, serving on Committees for the Inter-professional Relations/Physicians, Fee Disputes and Grievances. Further, he is involved with the Association of Trial Lawyers of America, Texas Trial Lawyers Association and the College of State Bar of Texas Mr. Cartwright, for 41 years specialized in business litigation, before selling his law firm in 2021 to serve as Chairman for SarcoMed USA. 

ABOUT SARCOMED USA

SarcoMedUSA was formed to investigate if an inhaled DNase 1 therapy could infuence the chronic pulmonary infammation seen in Pulmonary Sarcoidosis patients.

Scroll to Top